A new study projects nearly 1 billion people will be living with osteoarthritis, the most common form of arthritis, by 2050. Currently, 15% of individuals aged 30 and […]
Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by […]
Anxiety and depression are the mental health issues most commonly associated with inflammatory arthritis, and it is well-established that there is a link between mental health issues and […]
The typical person living with arthritis in the UK is 20% less likely to be in work than their equivalent without the condition, new research shows. And the […]
New research published in Arthritis & Rheumatology links parental smoking with an elevated risk of rheumatoid arthritis in children when they reach adulthood. Among 90,923 participants in the Nurses’ Health […]
EULAR President, Professor Annamaria Iagnocco, said: “EULAR is aware that more and more EU member states are experiencing shortages of essential anti-inflammatory drugs and that certain manufacturers have […]
AbbVie announced that the FDA has extended the review period for the supplemental New Drug Application (sNDA) for upadacitinib in the treatment of adult patients with active psoriatic […]
Combination treatment of COVID-19 patients with the antiinflammatory, arthritis drug baricitinib plus the antiviral drug remdesivir was superior to remdesivir monotherapy for cutting recovery time and improving symptoms. […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
